WallStSmart

Ferrari NV (RACE)vsXpeng Inc (XPEV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Xpeng Inc generates 926% more annual revenue ($75.41B vs $7.35B). RACE leads profitability with a 22.3% profit margin vs -4.1%. RACE earns a higher WallStSmart Score of 58/100 (C).

RACE

Buy

58

out of 100

Grade: C

Growth: 6.7Profit: 9.0Value: 2.7Quality: 6.5
Piotroski: 6/9Altman Z: 1.44

XPEV

Avoid

32

out of 100

Grade: F

Growth: 6.0Profit: 2.0Value: 6.7Quality: 4.5
Piotroski: 6/9Altman Z: 0.43
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

RACESignificantly Overvalued (-65.1%)

Margin of Safety

-65.1%

Fair Value

$250.64

Current Price

$413.78

$163.14 premium

UndervaluedFair: $250.64Overvalued
XPEVUndervalued (+85.0%)

Margin of Safety

+85.0%

Fair Value

$120.81

Current Price

$10.54

$110.27 discount

UndervaluedFair: $120.81Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

RACE4 strengths · Avg: 9.5/10
Return on EquityProfitability
44.8%10/10

Every $100 of equity generates 45 in profit

Operating MarginProfitability
31.1%10/10

Strong operational efficiency at 31.1%

Market CapQuality
$71.78B9/10

Large-cap with strong market position

Profit MarginProfitability
22.3%9/10

Keeps 22 of every $100 in revenue as profit

XPEV1 strengths · Avg: 8.0/10
Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Areas to Watch

RACE4 concerns · Avg: 3.0/10
P/E RatioValuation
37.9x4/10

Premium valuation, high expectations priced in

Price/BookValuation
17.2x4/10

Trading at 17.2x book value

PEG RatioValuation
3.432/10

Expensive relative to growth rate

Altman Z-ScoreHealth
1.442/10

Distress zone — elevated risk

XPEV4 concerns · Avg: 2.3/10
Debt/EquityHealth
1.513/10

Elevated debt levels

Return on EquityProfitability
-11.5%2/10

ROE of -11.5% — below average capital efficiency

EPS GrowthGrowth
-10.2%2/10

Earnings declined 10.2%

Altman Z-ScoreHealth
0.432/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : RACE

The strongest argument for RACE centers on Return on Equity, Operating Margin, Market Cap. Profitability is solid with margins at 22.3% and operating margin at 31.1%.

Bull Case : XPEV

The strongest argument for XPEV centers on Price/Book.

Bear Case : RACE

The primary concerns for RACE are P/E Ratio, Price/Book, PEG Ratio.

Bear Case : XPEV

The primary concerns for XPEV are Debt/Equity, Return on Equity, EPS Growth. Debt-to-equity of 1.51 is elevated, increasing financial risk.

Key Dynamics to Monitor

RACE profiles as a mature stock while XPEV is a turnaround play — different risk/reward profiles.

XPEV carries more volatility with a beta of 1.10 — expect wider price swings.

RACE is growing revenue faster at 8.4% — sustainability is the question.

Monitor AUTO MANUFACTURERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

RACE scores higher overall (58/100 vs 32/100), backed by strong 22.3% margins. XPEV offers better value entry with a 85.0% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Ferrari NV

CONSUMER CYCLICAL · AUTO MANUFACTURERS · USA

Ferrari NV designs, designs, produces and sells high performance sports cars. The company is headquartered in Maranello, Italy.

Xpeng Inc

CONSUMER CYCLICAL · AUTO MANUFACTURERS · USA

XPeng Inc. designs, develops, manufactures and markets smart electric vehicles in the People's Republic of China. The company is headquartered in Guangzhou, the People's Republic of China.

Visit Website →

Want to dig deeper into these stocks?